FDA Inspection 636237 — Anne Arundel Medical Center Irb
The FDA completed an inspection of Anne Arundel Medical Center Irb on December 9, 2009 in Annapolis, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 9, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Annapolis, MD (United States)
Additional Details
IRB